Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

AGM Statement

28 Jul 2011 07:00

RNS Number : 2159L
Halma PLC
28 July 2011
Β 

ο»Ώ

Halma p.l.c.

Β 

AGM Trading Update/Interim Management Statement

Β 

28 July 2011

Β 

Β 

Halma, the leading safety, health and environmental technology group is holding its 117th AGM later today, at which Geoff Unwin, Chairman, will make the following statement which comprises the Group's Interim Management Statement relating to the period 3 April 2011 to 28 July 2011 and covers the first quarter's trading.

Β 

"Trading since the start of the financial year has been in line with the Board's expectations.

Β 

"In the first quarter, revenue was 14% ahead of last year, including a positive benefit of 8% from acquisitions and a negative impact of 2% from currency translation. Order intake was slightly ahead of revenue.

Β 

"All three sectors increased revenue and profit. Health and Analysis is benefiting strongly from the expected contribution of recent acquisitions, whilst Infrastructure Sensors is making steady progress. Industrial Safety continued to make good progress following a strong improvement in the last financial year.

Β 

"Revenue growth in UK and Europe is encouraging and exceeds the rate of growth in the USA. Good progress continues to be made in Asia.

Β 

"Since the start of the financial year, Halma has announced the completion of two acquisitions. In May, we acquired Kirk Key Interlocks, based in Ohio, USA for $14.7m (Β£9.0m) and in July we acquired AVO Photonics, based in Pennsylvania, USA for an initial consideration of $9m (Β£5.6m). Both businesses are trading in line with expectations as part of our Safety Interlocks (Industrial Safety) and Photonics (Health & Analysis) businesses respectively.

Β 

"There have been no material events or transactions impacting the Group's financial position, which remains strong. We continue to increase investment in supporting organic growth and to acquire businesses which meet our strategic and financial criteria.

Β 

"The half yearly results for the period ending 1 October 2011 are expected to be released on 22 November 2011."

Β 

Β 

Β 

For further information, please contact:

Β 

Halma p.l.c.

Andrew Williams, Group Chief Executive

Kevin Thompson, Group Finance Director

Β 

Tel: +44 (0)1494 721111

Β 

MHP Communications

Rachel Hirst/Andrew Jaques

Tel: +44 (0)20 3128 8100

Β 

Notes:

Β 

1.

This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Halma p.l.c., in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

Β 

2.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
AGMDKODKABKDQOB
Date   Source Headline
15th Oct 20211:06 pmRNSDirector/PDMR Shareholding
4th Oct 20212:12 pmRNSDirector/PDMR Shareholding
23rd Sep 20211:01 pmRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading update
9th Sep 202110:22 amRNSDirector Declaration
9th Aug 20217:00 amRNSM&A Update
26th Jul 202111:01 amRNSDirector/PDMR Shareholding
22nd Jul 20213:00 pmRNSResult of AGM
5th Jul 20214:05 pmRNSDirector/PDMR Shareholding
30th Jun 20211:50 pmRNSDirector/PDMR Shareholding
23rd Jun 20214:47 pmRNSAnnual Financial Report
10th Jun 20217:01 amRNSUnaudited restated segmental information
10th Jun 20217:00 amRNSFull Year Results 2021
27th Apr 20217:00 amRNSAcquisition
26th Mar 20217:00 amRNSAppointment of independent non-executive Director
24th Mar 20217:00 amRNSTrading update
23rd Feb 20217:54 amRNSDirector Declaration
10th Feb 20214:52 pmRNSDirector/PDMR Shareholding
9th Feb 20217:00 amRNSDirectorate Change
21st Dec 20202:00 pmRNSAcquisition
18th Dec 20207:00 amRNSDisposal
4th Dec 20207:04 amRNSDirector Declaration
2nd Dec 20204:08 pmRNSDirector/PDMR Shareholding
25th Nov 20203:20 pmRNSDirector/PDMR Shareholding
19th Nov 20207:00 amRNSHALF YEAR RESULTS 2020/21
5th Oct 20201:12 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:05 amRNSDirector Declaration
23rd Sep 20207:00 amRNSChair retirement
23rd Sep 20207:00 amRNSTrading update
4th Sep 20204:57 pmRNSResult of AGM
31st Jul 20204:06 pmRNSDirector/PDMR Shareholding
24th Jul 20205:02 pmRNSAnnual Financial Report
17th Jul 20209:32 amRNSDirector/PDMR Shareholding
14th Jul 20207:00 amRNSFinal Results
15th May 20201:29 pmRNSElectronic Communications with Shareholders
27th Apr 202012:46 pmRNSDisclosure of Rights Attached to Equity Shares
21st Apr 20207:00 amRNSCOVID-19 Update
2nd Apr 20207:05 amRNSExecutive Board changes
19th Mar 20207:00 amRNSTrading Statement
5th Mar 20209:00 amRNSInvestor Event
24th Feb 202011:31 amRNSHolding(s) in Company
21st Feb 20207:00 amRNSAcquisition
5th Feb 20207:00 amRNSAcquisition
27th Jan 20207:00 amRNSAcquisition
22nd Jan 202012:58 pmRNSChange of Remuneration Committee Chair
29th Nov 20191:27 pmRNSDirector/PDMR Shareholding
25th Nov 20195:10 pmRNSDirector/PDMR Shareholding
19th Nov 201911:45 amRNSDividend Declaration
19th Nov 20197:00 amRNSHalf-year Report
2nd Oct 20195:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.